“April Crawford never thought she’d be begging for help on GoFundMe, but she has run out of options,” Gina Kolata and Francesca Paris write over at The New York Times. “She has multiple sclerosis, and Mavenclad, the drug that could slow her decline, has a list price of $194,000 a year. Her Medicare insurance will pay […]
